Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dankner

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Neuro-Oncology Advances|December 16, 2024
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scansKeyhan Najafian, Benjamin Rehany, Alexander Nowakowski, et al.
JAMA Oncology|March 21, 2024
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-AnalysisMark Sorin, Connor Prosty, Louis Ghaleb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant MelanomasMatthew Dankner, Mathieu Lajoie, Dan Moldoveanu, et al.
JCO Precision Oncology|January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic CancersMatthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
Breast Cancer Research : BCR|January 17, 2020
p66ShcA functions as a contextual promoter of breast cancer metastasisKyle Lewis, Alex Kiepas, Jesse Hudson, et al.
Breast (Edinburgh, Scotland)|May 8, 2023
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, et al.
Neuro-Oncology|January 25, 2024
Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytesMatthew Dankner, Sarah M Maritan, Neibla Priego, et al.
Neuro-Oncology|January 12, 2021
Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastasesMatthew Dankner, Maxime Caron, Tariq Al-Saadi, et al.
JCI Insight|May 22, 2026
Distinct immune landscapes characterize highly versus minimally invasive brain metastasesSarah M Maritan, Elham Karimi, Matthew Dankner, et al.
Communications Biology|June 18, 2020
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumorsPaul Savage, Alain Pacis, Hellen Kuasne, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Neuro-Oncology Advances|December 16, 2024
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scansKeyhan Najafian, Benjamin Rehany, Alexander Nowakowski, et al.
JAMA Oncology|March 21, 2024
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-AnalysisMark Sorin, Connor Prosty, Louis Ghaleb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant MelanomasMatthew Dankner, Mathieu Lajoie, Dan Moldoveanu, et al.
JCO Precision Oncology|January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic CancersMatthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
Breast Cancer Research : BCR|January 17, 2020
p66ShcA functions as a contextual promoter of breast cancer metastasisKyle Lewis, Alex Kiepas, Jesse Hudson, et al.
Breast (Edinburgh, Scotland)|May 8, 2023
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, et al.
Neuro-Oncology|January 25, 2024
Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytesMatthew Dankner, Sarah M Maritan, Neibla Priego, et al.
Neuro-Oncology|January 12, 2021
Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastasesMatthew Dankner, Maxime Caron, Tariq Al-Saadi, et al.
JCI Insight|May 22, 2026
Distinct immune landscapes characterize highly versus minimally invasive brain metastasesSarah M Maritan, Elham Karimi, Matthew Dankner, et al.
Communications Biology|June 18, 2020
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumorsPaul Savage, Alain Pacis, Hellen Kuasne, et al.
Pageof 4